S100A8 BUT NOT S100A9 LEVEL IS RELATED TO THE EXTENT OF EROSIVE BONE DAMAGE IN PSORIATIC ARTHRITIS PATIENTS
Simon D, Nas K, Faustini F, Kleyer A, Haschka J, Englbrecht M, Hueber A, Kocijan R, Sticherling M, Schett G, Rech J (2016)
Publication Type: Conference contribution
Publication year: 2016
Journal
Book Volume: 75 2
Pages Range: 1225-1225
Authors with CRIS profile
David Simon
Department of Medicine 3 – Rheumatology and Immunology
Arnd Kleyer
Department of Medicine 3 – Rheumatology and Immunology
Matthias Englbrecht
Lehrstuhl für Innere Medizin III
Axel Hueber
Department of Medicine 3 – Rheumatology and Immunology
Michael Sticherling
Professur für Dermatologie
Georg Schett
Lehrstuhl für Innere Medizin III
Jürgen Rech
Department of Medicine 3 – Rheumatology and Immunology
Involved external institutions
Sakarya Üniversitesi (Sakarya University)
Turkey (TR)
Karolinska Institute
Sweden (SE)
St. Vincentius-Kliniken / ViDia Christliche Kliniken Karlsruhe
Germany (DE)
Turkey (TR)
Karolinska Institute
Sweden (SE)
St. Vincentius-Kliniken / ViDia Christliche Kliniken Karlsruhe
Germany (DE)
How to cite
APA:
Simon, D., Nas, K., Faustini, F., Kleyer, A., Haschka, J., Englbrecht, M.,... Rech, J. (2016). S100A8 BUT NOT S100A9 LEVEL IS RELATED TO THE EXTENT OF EROSIVE BONE DAMAGE IN PSORIATIC ARTHRITIS PATIENTS. (pp. 1225-1225).
MLA:
Simon, David, et al. "S100A8 BUT NOT S100A9 LEVEL IS RELATED TO THE EXTENT OF EROSIVE BONE DAMAGE IN PSORIATIC ARTHRITIS PATIENTS." 2016. 1225-1225.
BibTeX: Download